Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas
- 1 January 2003
- journal article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 26 (1) , 23-28
- https://doi.org/10.1007/bf03345118
Abstract
Microvessel density (MVD) represents a measure of angiogenesis and may be used as an indicator of neoplastic aggressiveness. Vascular endothelial growth factor (VEGF) plays a pivotal role as angiogenic promoter by stimulating endothelial cell proliferation and migration and enhancing vascular permeability. The aim of this study was to investigate MVD and VEGF expression in human pituitary adenomas and normal pituitary gland tissues by immunohistochemistry, and to correlate data with clinical characteristics. Fragments from 46 pituitary adenomas (18 non-functioning, 12 ACTH-secreting, 12 GH-secreting, 4 PRL-secreting) and 19 specimens of normal anterior pituitary gland obtained at surgery were evaluated. MVD in normal anterior pituitary was significantly higher than in tumors (69.2±28.5 vs 29.3±19.7; p<0.0001). Within adenomas, no difference was found in MVD when different histotype, size, sex, age, rate of recurrence or medical pre-surgical treatment were considered. The degree of vascularity was somewhat related only to clinical invasiveness, as evaluated by pre-surgical MRI grading (grade 0 p<0.05 vs grade 1 and vs grade 2). No statistically significant difference in VEGF expression was found between normal tissue and adenomas and among tumors of different histotype (p= 0.3978). Size, sex, age, rate of recurrence and medical pre-surgical treatment did not influence VEGF expression. No correlation was found between MVD and VEGF expression. In conclusion, MVD was reduced in pituitary adenomas with respect to normal gland. VEGF expression is however well preserved in adenomas and this might contribute to adequate tumoral vascular supply with complex mechanisms other than endothelial cells proliferation.Keywords
This publication has 25 references indexed in Scilit:
- Vascular Endothelial Growth Factor Production and Regulation in Rodent and Human Pituitary Tumor Cells in vitroNeuroendocrinology, 2001
- Different features of angiogenesis between ovarian and breast carcinomaCancer Letters, 2001
- Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditionsNature Medicine, 2001
- Proliferation, bcl-2 expression and angiogenesis in pituitary adenomas: relationship to tumour behaviourBritish Journal of Cancer, 2000
- Angiogenesis in Pituitary Adenomas and the Normal Pituitary GlandJournal of Clinical Endocrinology & Metabolism, 2000
- Expression of vascular endothelial growth factor in human brain tumorsActa Neuropathologica, 1998
- Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancerInternational Journal of Cancer, 1997
- Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancerThe Lancet, 1992
- Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cellsPublished by Elsevier ,1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990